December 2015: The Antibody Update – Antibody Engineering and Therapeutics Conference Highlights The Antibody Engineering and Therapeutics conference held in San Diego was a fantastic exchange of knowledge between all the participants. One of the many topics that stuck out...
Share this post:
Bacteria with Resistance to Polymyxins, the Last Form of Antibiotics, Have Been Found in China Strains of E. coli that are resistant to polymyxin class antibiotics have been found in both pigs and citizens in China. Polymyxins were the last...
Share this post:
An article published by Nature earlier this year pointed out that researchers now have to worry about the reproducibility of production antibodies. The fact of the matter is that off-the-shelf antibodies from large distributors can be unreliable tools, often functioning...
Share this post:
Antibody development is multi-faceted process that begins with the target to which you wish to develop antibodies against: the antigen. To elicit an immune response we must select the appropriate adjuvant to be mixed with the antigen for immunization. Which...
Share this post:
October 2015: The Antibody Update – Antibody Against an Alzheimer’s Associate Protein Presented at the 2015 Society for Neuroscience Conference At the Society for Neuroscience (SfN) conference in Chicago, an abstract was presented by a Harvard research team about an...
Share this post:
Antibody Basics: Hybridoma – Hybridoma Development Hybridoma technology is the core technique used to develop monoclonal antibodies at ProSci. A hybridoma is a single cell that consists of a cancerous myeloma cell and an immune B-cell which have been fused...
Share this post:
New Antibody Targets HIV Glycoprotein at Different Conformations Caltech has discovered a broadly neutralizing antibody (bNAb) that can bind to both partially open and closed conformation of the HIV-1 envelope glycoprotein. Typically bNAbs only target the HIV-1 envelope in a...
Share this post:
The Start of ProSci ProSci’s Antibody Experts Published in Vaccine! – In 1984, human immunodeficiency virus type 1(HIV-1) was first discovered to be the cause of Acquired Immune Deficiency Syndrome(AIDS) pandemic, a fatal disease with 7,239 cases and 5,596 deaths...
Share this post:
August 2015: The Antibody Update – The biotechnology industry is defined by cutting edge discoveries, breakthrough therapies, and new research methods. ProSci is here to help you keep up. As a major player in Custom Antibody Development, it is our...
Share this post:
Antibody Basics: Monoclonal, Polyclonal, and Recombinant Antibodies – While simple in principle, antibodies are deceivingly complex in structure and production. Do you know the advantages and disadvantages of monoclonal, polyclonal and recombinant antibody production? Let ProSci be your expert. Polyclonal...
Share this post:
